Estradiol / Norethindrone Acetate Tablet, Film Coated
Product Images NDC 51991-474
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Estradiol / Norethindrone Acetate (NDC 51991-474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Norethindrone 02
Norethindrone 03
Norethindrone 04
Norethindrone 05
Norethindrone 06
This is a table showing the number of moderate to severe hot flushes over a 12-week period for two groups of participants: one group of 194 people taking Estradiol/Norethindrone Acetate Tablets 0.5 mg/0.1 mg, and one group of 199 people taking a placebo. The table shows data for week 10 and week 12.*
Norethindrone 07
Norethindrone 08
Norethindrone 09
This is a chart showing the change (%) in the effectiveness of different tablets, such as Estradiol/Norethindrone Acetate Tablets 1.0 mg/0.5 mg, Estradiol 0.5 mg, and Placebo, over a period of 5 lunar months (28-day cycles). The data is based on different national samples - EU and US, with varying numbers for each.*
Norethindrone 10
Norethindrone 11
This is a description of the packaging for Estradiol / Norethindrone Acetate Tablets, containing 28 tablets with a strength of 1.0 mg / 0.5 mg. The National Drug Code (NDC) for this medication is 51991-474-28. There are various numbers and codes on the packaging, including a prescription designation and a distributor name, but no further information is provided.*
Norethindrone 12
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.